Bank of Montreal
AVIR icon

Bank of Montreal’s Atea Pharmaceuticals AVIR Stock Holding History

Bank of Montreal’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-14,692
Closed -$49.2K – 3968
2023
Q1 		$49.2K Buy
+14,692
New +$59.6K ﹤0.01% 3373
2021
Q4 		– Sell
-36,106
Closed -$1.17M – 3498
2021
Q3 		$1.17M Buy
+36,106
New +$1M ﹤0.01% 2388
2021
Q2 		– Sell
-420
Closed -$24K – 3738
2021
Q1 		$24K Sell
420
-1,840
-81% -$124K ﹤0.01% 3976
2020
Q4 		$106K Buy
+2,260
New +$72.8K ﹤0.01% 3549

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal's AVIR Position: Q2 2023 in Review

Bank of Montreal sold out of Atea Pharmaceuticals (AVIR) in Q2 2023, closing a stake of 14,692 shares — an estimated $49.2K sold.

Bank of Montreal first reported a position in AVIR in Q4 2020 and held it in 4 quarters. The position peaked at $1.17M in Q3 2021. 133 funds tracked by Wall St. Rank hold AVIR as of Q2 2023.

  • Bank of Montreal reported no remaining Atea Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Bank of Montreal sold 14,692 Atea Pharmaceuticals shares in Q2 2023, an estimated $49.2K.
  • Bank of Montreal first reported a position in Atea Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Bank of Montreal's Atea Pharmaceuticals position peaked at $1.17M in Q3 2021.
  • 133 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.